Scrip: industry news and insights
Banking Crisis Prompts Postponed Noile-Immune IPO, But Wider Japan Views Mixed
29 Mar 2023
While the SVB and wider banking crisis has shaken VCs and bioventures in the US and Europe, Japan has mixed...
Watch Our Award Winning Webinar – Winner Of The 2020 SIPAwards For Best Webinar, Elearning Or Online Training Program.
Join pharma industry leaders from Merck and GlaxoSmithKline and experts from Pharma Intelligence as they present data and their own experiences in the growing use of Real World Evidence (RWE) for R&D, regulatory, and reimbursement purposes.
The webinar covers:
The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Pharma Intelligence suite of intelligence solutions. More than just news, Pink Sheet delivers analysis, and commentary focused on regulatory implications, including high-value perspectives from insiders and thought leaders across the globe – giving regulatory professionals an objective view of how to anticipate challenges, minimize risks, and maximize opportunities for their business. Scrip boasts over 60 journalists and analysts dedicated to bringing you the latest news and insights with everything from licensing, clinical trials, and competitor activity. Hear directly from the newsmakers, leverage best-in-class proprietary data, and follow the latest market developments with a Scrip account.
Download: How RWE is playing out in the real world webinar slides.
Scrip: industry news and insights
29 Mar 2023
While the SVB and wider banking crisis has shaken VCs and bioventures in the US and Europe, Japan has mixed...
Scrip: industry news and insights
28 Mar 2023
Latecomer PD-1/L1 drug Jemperli has achieved impressive Phase III results in first line endometrial cancer, and GSK hopes it can...
Scrip: industry news and insights
28 Mar 2023
Latecomer PD-1/L1 drug Jemperli has achieved impressive Phase III results in first line endometrial cancer, and GSK hopes it can...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: